Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 386 (OTC: $EDXC) (CSE: $GGB.C) (OTCQB: $GGBXF) (CSE: $VIBE.C) (TSXV: $KHRN.V) (OTCQB: $KHRNF)
Delta, Kelowna, BC, March 20th, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/03201EDXC-GGB-GGBXF-VIBE-KHRN-KHRNF.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few company announcements.
CBD Unlimited, Inc.
(OTC: EDXC), formerly known as Endexx
Corporation, a provider of innovative phytonutrient-based food and nutritional
products, announced that Daniel S. Brandwein, D.P.M.,
F.A.C.F.A.S., Florida board-certified foot and ankle surgeon, joined the Board
of Directors.
“I
am honored to serve as a board member for CBD Unlimited and will continue to
promote the advancement of CBD use as part of patients’ overall health and
wellness protocol,” commented Dr. Brandwein. “During an original clinical study
in 2015, which was supported by CBD Unlimited, I observed and administered a
CBD trial for one month through my practice. After the month-long trial, my
patients were reporting relief from pain and tension. From there, I knew that I
needed to be part of something special and cutting-edge in order to provide the
very best care to my patients and to patients around the world.”
Daniel
S. Brandwein, D.P.M., F.A.C.F.A.S. is a board-certified surgeon specializing in
the field of podiatry. In addition to Dr. Brandwein’s expertise in pain
management and therapeutic treatments, Dr. Brandwein has participated in
clinical trials and has authored several scientific papers.
"Dr.
Brandwein witnessed exceptional outcomes in early-stage clinical studies
sponsored by CBD Unlimited and now his patients, as well as countless other patients,
rely on CBD Unlimited’s products as part of their day-to-day health regimen,”
commented Mr. Todd Davis, Chairman and Chief Executive Officer of CBD
Unlimited. “We are thrilled to welcome such a distinguished and accomplished
individual to our Advisory Board. Dr. Brandwein’s clinical expertise will prove
to be a significant advantage in the long-term objectives of the company,”
continued Davis.
CBD
Unlimited, Inc. develops and distributes all-natural CBD products derived from
cannabis sativa plant (Hemp), containing less than 0.01% THC. Its products
range from oils, capsules, topicals, and pet products, all with the shared
purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD
soft chews for animal use that are formulated to promote health and support the
reduction of separation anxiety, pain, and inflammation. The science behind
these products involves over half a decade of research and experiments in order
to protect the accuracy in dosage and delivery of absorption per each serving.
Green Growth Brands
Inc.
(CSE: GGB) (OTCQB: GGBXF) announced that Peter Horvath is stepping down
as Chief Executive Officer and as a member of the Board of Directors effective
today. Mr. Horvath has served as CEO of
the Company since January 2019 and as a member of the Company's Board of
Directors since July 2018. Randy
Whitaker, the Company's current Chief Operating Officer will take over as
interim Chief Executive Officer, effective immediately. Mr. Whitaker has served as the Company's
Chief Operating Officer since February 2019.
The vacancy on the Company's Board of Directors will be filled in due
course.
Ms.
Carli Posner, the Chair of the Board of Directors, said "On behalf of the
Board and everyone at GGB, I would like to offer my heartfelt thanks to Peter
for his significant contribution and dedication to the Company and wish Peter
the best for his future endeavours."
Mr.
Horvath responded, "I am humbled to have worked with such amazing
professionals along this journey. Among
those individuals is Randy Whitaker, whom I am pleased has been named as
interim CEO. The Company will be in good hands with such a seasoned operator at
the helm, and I have full confidence in Randy to lead the Company during this
difficult time."
In
response to the ongoing COVID-19 pandemic and in accordance with the
recommendations of health professionals and other mall-based retailers, the
Company has elected to temporarily close all of its mall-based cannabidiol
("CBD") kiosk shops in an
effort order to protect its employees and customers from unnecessary exposure
to the COVID-19 virus. In connection
with this action, the Company will also suspend sales under its CBD e-commerce
platform.
The
Company's cannabis dispensaries, located in the Las Vegas, Nevada area, will
remain open for business subject to additional pandemic-related directives from
local authorities. The Company will continue to employ best practices and
adhere to such directives related to its operations in light of the COVID-19
pandemic.
The
Company will continue to pursue the previously announced sale of the CBD
business to The BRN Group Inc. In connection therewith, the Company will
continue to solicit and evaluate any potential superior offers under the
go-shop rights afforded to the Company as part of that announced transaction.
Vibe
Bioscience Ltd. (CSE: VIBE) announced, effective immediately, that it is
offering contactless ‘Curb-side’ Pick-Up at all Vibe By California locations in
addition to touchless delivery options and additional in-store safety measures.
While preparations
and information continue to develop across California for COVID-19 , Vibe is
working to ensure our clients and staff remain healthy. Our priority is on the
safety and well-being of our employees and clients. We have always taken great
pride in our clean and well-run stores, and in addition to increased frequency
of cleaning for all our stores, Vibe has a dedicated team member working full
time cleaning all frequently touched surfaces. We are also:
●
Providing
complimentary delivery service in Sacramento for those 65 years of age
and older and those with a pre-existing medical condition;
●
Limiting the number of clients and staff
permitted inside our stores at any given time and encouraging clients to
maximize their distance between our staff and other clients to reduce
transmission dynamics and potential communicability;
●
Encouraging clients to complete their
purchases online using our website, ensuring online orders are accurate and
available for immediate pick-up; and
●
Obtained local and State approvals to
provide compliant touchless pickup options at all locations.
Vibe continues to
work closely with international and State public health authorities to monitor
the situation regarding the Coronavirus. We will continue to follow the
guidance of local and international health authorities to make informed
decisions and provide our clients and staff with information as we continue to
learn and improve our processes.
Everyone has a
vital role during the management of this outbreak. We are confident that together we will
overcome this challenge soon by taking the necessary protective measures and
working collectively as a unified community.
As this issue continues to evolve, we remain committed to supporting our
clients and valued team.
For more
information on our touchless delivery and curbside pick-up option, please visit
www.vibebycalifornia.com.
Khiron Life
Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced that the Company has received
certification of Good Elaboration Practices for Magistral Preparations with
Cannabis (GEP). As a result, the Company is now fully authorized to manufacture
high- and low-THC magistral preparations in Colombia. The Company anticipates
fulfilling its first prescriptions of full-spectrum, high CBD formulations
within days. The Company anticipates
that it will also be fully authorized to fulfill prescriptions and dispense
psychoactive (high-THC) medical cannabis within the coming weeks, once the
pharmacies are authorized by the Narcotics National Fund (FNE).
"Today
is a hugely important milestone for Khiron. With this GEP certification we
begin a new phase in commercializing our medical cannabis product pipeline and
towards meeting our market potential. We have been preparing for this day for
three years. We have the capacity, established patient network, and now full
authorization to manufacture high- and low-THC magistral preparations, and to
fulfill prescriptions for non-psychoactive medicinal cannabis within
days," comments Alvaro Torres, Khiron CEO and director. "From day one
our mission has always been to model our business on serving patient needs, and
now we are delivering on that focus, targeting the millions of patients in
Colombia who have the potential to benefit from medical cannabis."
Khiron
has an established patient network in Colombia through its ILANS medical
facilities that treat over 120,000 patients with neurological, psychiatric,
respiratory, urological and orthopedic diseases, among others. ILANS patients
are serviced by the Colombian health insurance system. The Company also recently
opened Zerenia, a 15,000 sq. ft facility in Bogota that increases the Company's
patient capacity by 75%, offering a comprehensive suite of health and medical
services in alignment with insurance company partners.
Under
Colombian regulations, GEP certification is a manufacturing and processing
certification that is a mandatory requirement for commercializing customized
medical cannabis prescriptions, known as Magistral Preparations.
Commercializing customized medical cannabis prescriptions in Colombia involves
a lengthy and rigorous regulatory process that has seen the Company receive
licenses to cultivate high-THC and low-THC cannabis for domestic and export
sales, quotas to cultivate 9.3 tons of THC cannabis, and to extract THC
cannabis in Colombia. To-date, Khiron is the only company in Colombia to meet
all of these strict regulatory requirements, and, with the GEP certification
received today, becomes the first Company authorized to sell medical cannabis
in Colombia.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
No comments:
Post a Comment